These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17708067)

  • 41. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
    Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
    Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coadministration of milk thistle and indinavir in healthy subjects.
    DiCenzo R; Shelton M; Jordan K; Koval C; Forrest A; Reichman R; Morse G
    Pharmacotherapy; 2003 Jul; 23(7):866-70. PubMed ID: 12885100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex differences in excipient effects: Enhancement in ranitidine bioavailability in the presence of polyethylene glycol in male, but not female, rats.
    Afonso-Pereira F; Murdan S; Sousa J; Veiga F; Basit AW
    Int J Pharm; 2016 Jun; 506(1-2):237-41. PubMed ID: 27085641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study on the influence of silymarin pretreatment on metabolism and disposition of metronidazole.
    Rajnarayana K; Reddy MS; Vidyasagar J; Krishna DR
    Arzneimittelforschung; 2004; 54(2):109-13. PubMed ID: 15038460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption.
    Plusquellec Y; Efthymiopoulos C; Duthil P; Houin G
    Med Eng Phys; 1999 Oct; 21(8):525-32. PubMed ID: 10672785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
    Jou MJ; Huang SC; Kiang FM; Lai MY; Chao PD
    J Pharm Pharmacol; 1997 Nov; 49(11):1072-5. PubMed ID: 9401940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.
    Christensen JM; Limsakun T; Smith BB; Hollingshead N; Huber M
    J Vet Pharmacol Ther; 2001 Feb; 24(1):23-33. PubMed ID: 11348484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of ranitidine and nizatidine in very elderly patients.
    Sasaki M; Sudoh T; Fujimura A
    Am J Ther; 2005; 12(3):223-5. PubMed ID: 15891265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosage regimen of ranitidine in patients with renal impairment.
    Ebihara A; Ohashi K; Ikeda T; Yuhara M; Tagawa H; Yamakado M; Asano Y; Tabei K; Nakazawa K; Kondo K
    Int J Clin Pharmacol Res; 1989; 9(1):1-7. PubMed ID: 2707920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of gender and phase of the menstrual cycle on the kinetics of ranitidine in healthy volunteers.
    Flores Pérez J; Juárez Olguín H; Flores Pérez C; Pérez Guillé G; Guillé Pérez A; Camacho Vieyra A; Toledo López A; Carrasco Portugal M; Lares Asseff I
    Chronobiol Int; 2003 May; 20(3):485-94. PubMed ID: 12868543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Simple and robust high-performance liquid chromatographic method for the determination of ranitidine in microvolumes of human serum.
    López-Calull C; García-Capdevila L; Arroyo C; Bonal J
    J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):228-32. PubMed ID: 9200540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
    Gschwend MH; Guserle R; Erenmemişoglu A; Martin W; Tamur U; Kanzik I; Hincal AA
    Arzneimittelforschung; 2007; 57(6):315-9. PubMed ID: 17688076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus.
    Knupp CA; Graziano FM; Dixon RM; Barbhaiya RH
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2075-9. PubMed ID: 1444287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of rifampicin pretreatment on the pharmacokinetics of celecoxib in healthy male volunteers.
    Jayasagar G; Krishna Kumar M; Chandrasekhar K; Madhusudan Rao Y
    Drug Metabol Drug Interact; 2003; 19(4):287-95. PubMed ID: 14768975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of antacids and ranitidine on the single-dose pharmacokinetics of fosamprenavir.
    Ford SL; Wire MB; Lou Y; Baker KL; Stein DS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):467-9. PubMed ID: 15616339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study on the bioequivalence of two ranitidine formulations.
    Hilgenstock C; Schmiedel G; Bührens KG
    Arzneimittelforschung; 1987 Aug; 37(8):974-6. PubMed ID: 3675698
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Solid-phase extraction and determination of ranitidine in human plasma by a high-performance liquid chromatographic method utilizing midbore chromatography.
    Farthing D; Brouwer KL; Fakhry I; Sica D
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):350-3. PubMed ID: 9061475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
    Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
    Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.